About Epijoint®

A pioneering Australian joint health company

A proudly family-owned Australian business since 1998, Interpath Global, the company behind Epijoint®, researches and develops a variety of joint health solution for humans and animals. Interpath's passion is to bring relief to those living with joint health issues.

epiItalis

The world-exclusive ingredient

Discovered by Interpath, Epiitalis® is globally patented for its anti-inflammatory properties and joint cartilage health benefits. Epijoint® with Epiitalis® relieves mild osteoarthritis symptoms including mild joint aches, pains, stiffness and inflammation.

Our unique formulation also:

  • Supports joint mobility.
  • Helps maintain joint cartilage health and growth.
  • Works as an antioxidant reducing free radicals formed in the body.
  • Supports overall immune system health.
  • Helps enhance general health and wellbeing.
Read more
research

Our successes

Epiitalis® has been involved in 20 years of rigorous scientific research, all over the globe. Its efficacy is backed by multiple scientific studies published in leading international journals.

In a recent human clinical trial examining the effects of Epiitalis® on reducing symptoms of mild osteoarthritis, results demonstrated a number of positive health outcomes.

View study

Mitchell P. G., et. al. Inflammopharmacology. 2022 Aug; 30(4):1323-1334. Interpath sponsored study. Research conducted by Vedic Lifesciences.

Dan and Corina Bright

Interpath FOUNDERS

Dan and Corina established Interpath Global in 1998 after their dog Sasha was diagnosed with osteoarthritis, and they questioned why there were no scientifically proven, natural joint health treatments available. This was the catalyst for a chain of events, that lead to them dedicating themselves to pushing scientific boundaries within the field of joint health for animals and humans, in order to help joint health sufferers better manage their conditions. Being able to move freely is such a central part of living life fully, and it is this that has driven them to invest heavily in the research and development of Epiitalis® - a world-exclusive active ingredient that is opening a new door for joint health sufferers.

Frequently asked questions

What is Epiitalis®?

Epiitalis®, the proprietary ingredient in Epijoint®, is harnessed from a plant seed oil, comprised of fatty acids. Epiitalis® is globally patented for its anti-inflammatory properties and cartilage health benefits.

How many capsules should I take?

The recommended daily dosage is 2 capsules per day. Up to 4 capsules can be taken if necessary.

Can I take Epijoint® if I am taking other medications?

Talk to your prescribing medical practitioner before taking other medicines.

How soon will I feel the benefits of Epijoint®?

While individual results vary, most people report an improvement in 7 to 30 days after consistent daily use.

See all